Welip (M) Sdn Bhd · 66-41 · MALAYSIA
For Welip (M) Sdn Bhd, import alert is 66-41; country is MALAYSIA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Linsen Double Caulis Capsules; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is listed twice: 10/22/2025 and 12/24/2013; address is listed twice: NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA and Lot 1892 Riverview Arcade Kuchin , Sarawak, MALAYSIA, verified against its source on 2026-10-01.
- Firm
- Welip (M) Sdn Bhd verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- MALAYSIA verified
- Address
- NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA verified
- Lot 1892 Riverview Arcade Kuchin , Sarawak, MALAYSIA also listed
- Date published
- 10/22/2025 verified
- 12/24/2013 also listed
- Product code
- 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. verified
- Product
- Linsen Double Caulis Capsules verified
- FDA notes
- Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.” verified
What the source says
Welip (M) Sdn Bhd Date Published : 10/22/2025 NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 10/22/2025 Desc: Linsen Double Caulis Capsules Notes: Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.”
— all from accessdata.fda.gov, retrieved 2026-09-15
The same source also states
Welip (M) Sdn Bhd Date Published : 12/24/2013 Lot 1892 Riverview Arcade Kuchin , Sarawak, MALAYSIA
— accessdata.fda.gov, retrieved 2026-09-24
Product code
66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 12/24/2013 Desc: Kian Pee Wah 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 12/24/2013 Desc: Ceng Fui Yen
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html